Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.40
HNSN's Cash to Debt is ranked higher than
61% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.11 vs. HNSN: 0.40 )
HNSN' s 10-Year Cash to Debt Range
Min: 0.4   Max: No Debt
Current: 0.4

Equity to Asset 0.15
HNSN's Equity to Asset is ranked higher than
50% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. HNSN: 0.15 )
HNSN' s 10-Year Equity to Asset Range
Min: -0.06   Max: 0.9
Current: 0.15

-0.06
0.9
F-Score: 4
Z-Score: -10.51
M-Score: -0.47
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -211.87
HNSN's Operating margin (%) is ranked higher than
50% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.19 vs. HNSN: -211.87 )
HNSN' s 10-Year Operating margin (%) Range
Min: -531.5   Max: -70.79
Current: -211.87

-531.5
-70.79
Net-margin (%) -243.60
HNSN's Net-margin (%) is ranked higher than
51% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. HNSN: -243.60 )
HNSN' s 10-Year Net-margin (%) Range
Min: -499.96   Max: -75.52
Current: -243.6

-499.96
-75.52
ROE (%) -416.46
HNSN's ROE (%) is ranked lower than
52% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.39 vs. HNSN: -416.46 )
HNSN' s 10-Year ROE (%) Range
Min: -267.8   Max: -52.02
Current: -416.46

-267.8
-52.02
ROA (%) -88.46
HNSN's ROA (%) is ranked lower than
51% of the 316 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. HNSN: -88.46 )
HNSN' s 10-Year ROA (%) Range
Min: -252.93   Max: -24.81
Current: -88.46

-252.93
-24.81
ROC (Joel Greenblatt) (%) -196.29
HNSN's ROC (Joel Greenblatt) (%) is ranked higher than
54% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.21 vs. HNSN: -196.29 )
HNSN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2411.13   Max: -152.22
Current: -196.29

-2411.13
-152.22
Revenue Growth (%) -14.80
HNSN's Revenue Growth (%) is ranked higher than
56% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. HNSN: -14.80 )
HNSN' s 10-Year Revenue Growth (%) Range
Min: 0   Max: -10.2
Current: -14.8

EBITDA Growth (%) -3.00
HNSN's EBITDA Growth (%) is ranked higher than
65% of the 240 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. HNSN: -3.00 )
HNSN' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 121.1
Current: -3

0
121.1
EPS Growth (%) -3.50
HNSN's EPS Growth (%) is ranked higher than
66% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. HNSN: -3.50 )
HNSN' s 10-Year EPS Growth (%) Range
Min: -50   Max: 122.8
Current: -3.5

-50
122.8
» HNSN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

HNSN Guru Trades in

Q2 2012

HNSN Guru Trades in Q2 2012

Chuck Royce Sold Out
» More
Q1 2014

HNSN Guru Trades in Q1 2014

George Soros 120,000 sh (New)
» More
Q2 2014

HNSN Guru Trades in Q2 2014

George Soros Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HNSN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2014-06-30 Sold Out $1.19 - $2.75 $ 0.96-45%0
George Soros 2014-03-31 New Buy$1.65 - $2.59 $ 0.96-57%120000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 13.71
HNSN's P/B is ranked lower than
60% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.99 vs. HNSN: 13.71 )
HNSN' s 10-Year P/B Range
Min: 1.55   Max: 30.13
Current: 13.71

1.55
30.13
P/S 4.36
HNSN's P/S is ranked higher than
53% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. HNSN: 4.36 )
HNSN' s 10-Year P/S Range
Min: 2.75   Max: 224.91
Current: 4.36

2.75
224.91
EV-to-EBIT -3.30
HNSN's EV-to-EBIT is ranked higher than
61% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.53 vs. HNSN: -3.30 )
HNSN' s 10-Year EV-to-EBIT Range
Min: -20.1   Max: -0.9
Current: -3.3

-20.1
-0.9
Current Ratio 3.82
HNSN's Current Ratio is ranked higher than
84% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. HNSN: 3.82 )
HNSN' s 10-Year Current Ratio Range
Min: 1.45   Max: 26.06
Current: 3.82

1.45
26.06
Quick Ratio 2.82
HNSN's Quick Ratio is ranked higher than
83% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.82 vs. HNSN: 2.82 )
HNSN' s 10-Year Quick Ratio Range
Min: 1.04   Max: 26.06
Current: 2.82

1.04
26.06

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 13.71
HNSN's Price/Tangible Book is ranked lower than
57% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. HNSN: 13.71 )
HNSN' s 10-Year Price/Tangible Book Range
Min: 1.89   Max: 24.25
Current: 13.71

1.89
24.25
Price/Median PS Value 0.64
HNSN's Price/Median PS Value is ranked higher than
92% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. HNSN: 0.64 )
HNSN' s 10-Year Price/Median PS Value Range
Min: 0.45   Max: 25.19
Current: 0.64

0.45
25.19
Earnings Yield (Greenblatt) -30.30
HNSN's Earnings Yield (Greenblatt) is ranked lower than
87% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. HNSN: -30.30 )
HNSN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -30.3

Forward Rate of Return (Yacktman) -135.97
HNSN's Forward Rate of Return (Yacktman) is ranked higher than
51% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.38 vs. HNSN: -135.97 )
HNSN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -580.8   Max: -79.3
Current: -135.97

-580.8
-79.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:H9M.Germany
Hansen Medical, Inc. develops, manufactures and markets new generation of medical robotics for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Magellan Robotic System and Lynx.
» More Articles for HNSN

Headlines

Articles On GuruFocus.com
Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure i Oct 21 2014 
5-year lows: Layne Christensen Co, Hansen Medical Inc, API Technologies Corp, and Female Health Co. Jul 27 2014 
Hansen Medical possibly the next Intuitive Surgical Jul 27 2011 
Hansen Medical Possibly The Next Intuitive Surgical Jul 27 2011 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q) May 10 2010 
Weekly CEO Buys Highlight: Hansen Medical Inc., Trans World Entertainment Corp, Winmark Corp, ZEP IN Apr 24 2010 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q/A) Nov 16 2009 
HANSEN MEDICAL, INC. Reports Operating Results (10-Q) Aug 06 2009 
Weekly CEO Buy Highlights: Huntington Bancshares, Brown & Brown Inc, The Greenbrier Companies, Prosp Apr 25 2009 


More From Other Websites
Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure... Oct 21 2014
Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure... Oct 21 2014
Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs Oct 20 2014
Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs Oct 20 2014
HANSEN MEDICAL INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Oct 09 2014
Study Finds Sensei(R) Robotic System Associated With Statistically Significant Improved Success... Sep 17 2014
Hansen Medical Announces US Commercial Availability of Magellan(TM) Transport System Aug 27 2014
HANSEN MEDICAL INC Financials Aug 19 2014
Strength Seen in Hansen Medical (HNSN): Stock Rises 8.6% Aug 13 2014
HANSEN MEDICAL INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
Hansen Medical Inc Earnings Call scheduled for 5:00 pm ET today Jul 31 2014
HANSEN MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... Jul 31 2014
Hansen Medical Reports Second Quarter 2014 Results and $23 Million Financing Jul 31 2014
Q2 2014 Hansen Medical Inc Earnings Release - After Market Close Jul 31 2014
Hansen Medical Announces Exclusive Distribution With Adachi Co., Ltd. Jul 30 2014
Hansen Medical Announces Publication of Uterine Artery Embolization (UAE) Results Jul 29 2014
Hansen Medical (HNSN) Crumbles: Stock Falls by 6.2% Jul 08 2014
Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) Jul 01 2014
HANSEN MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 24 2014
HANSEN MEDICAL INC Files SEC form 8-K/A, Change in Directors or Principal Officers Jun 17 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK